PTK2 and hepatocellular carcinoma: Research indicates that Protein tyrosine kinase 2 (PTK2) stimulates the accumulation of β-catenin in the nucleus of HCC cells, thereby increasing Wnt/β-catenin signaling pathway activity, and in this way promoting stemness of CSCs and enhancing the tumorigenicity of HCC cells (109).